Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
XORTX Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
XRTX
New York
8731
https://www.xortx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for XORTX Therapeutics Inc
XORTX Welcomes New Member to the Board of Directors
- Apr 8th, 2024 11:30 am
XORTX Announces Participation in Spring 2024 Investor Conferences
- Apr 8th, 2024 11:00 am
XORTX Announces New Clinical Advisory Board Member
- Mar 27th, 2024 9:00 am
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
- Mar 19th, 2024 1:30 pm
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
- Mar 19th, 2024 9:00 am
XORTX Reprices Warrants Issued in Connection with Previous Private Placements
- Mar 11th, 2024 11:00 am
XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units
- Mar 4th, 2024 12:00 pm
XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units
- Feb 15th, 2024 12:00 pm
XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units
- Feb 2nd, 2024 1:46 am
XORTX Announces $2 Million Public Offering
- Jan 15th, 2024 12:00 pm
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
- Jan 3rd, 2024 12:00 pm
XORTX Announces US ATM Offering
- Nov 30th, 2023 12:30 pm
XORTX Meets Nasdaq Continued Listing Requirements
- Nov 29th, 2023 12:00 pm
XORTX Clarifies Timing for Share Consolidation
- Nov 10th, 2023 12:00 pm
XORTX Announces Share Consolidation
- Nov 8th, 2023 10:00 pm
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023
- Nov 2nd, 2023 11:00 am
XORTX Announces Results of Special Meeting of Shareholders
- Oct 27th, 2023 9:30 pm
XORTX Announces Date for Rescheduled Special Meeting of Shareholders
- Oct 25th, 2023 9:00 pm
XORTX Announces Rescheduling of Special Meeting of Shareholders
- Oct 25th, 2023 11:00 am
XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
- Oct 12th, 2023 11:00 am
Scroll